Page 3 - Granules India
Granules India gains on product in-licensing pact with US firm
The company's US arm has exclusive agreement with USpharma Windlas, LLC for product in-licensing
Updated On : 09 Jun 2016 | 2:00 PM IST
Granules acquires exclusive product rights from US pharma company
Windlas through its subsidiaries holds Abbreviated New Drug Applications (ANDAs) for Fingolimod, Prasugrel, Dronedarone and Lurasidone
 "Granules acquires exclusive product rights from US pharma company")
Updated On : 09 Jun 2016 | 12:23 PM IST
Granules India gets establishment inspection report from USFDA
For the inspection done at the company's Jeedimetla plant in Telangana
 "Granules India gets establishment inspection report from USFDA")
Updated On : 30 May 2016 | 4:20 PM IST
